Alexandros Sofias
RWTH Aachen University
Biography
Dr. Alexandros Sofias is the head of the “Immune Cell Targeting and Imaging” laboratory at the Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen, Germany. His research focuses on unraveling the intricate in vivo fate of cancer nanomedicine using multimodal and multiscale imaging techniques, and developing nanoimmunotherapeutics for targeting and manipulating the cancer-associated immune system in the tumor microenvironment, circulation, and hematopoietic organs.
His lab is funded by the prestigious JPI Fellowship from the Excellence Initiative of the German Research Foundation (DFG), as well as research grants from the German Cancer Aid (Krebshilfe), the Clinical Research Unit (CRU) program of the German Research Foundation (DFG, CRU 344), the START Program (Faculty of Medicine, RWTH), and the Euro-Bioimaging.
He serves as Conference Chair for the Controlled Release Society (CRS) 2027 Annual Meeting (Toronto, 12-15 July 2027), Elected Member of the European Society for Molecular Imaging (ESMI) Governing Board, Associate Editor for RSC Pharmaceutics, and Editorial Board Member for Advanced Drug Delivery Reviews (ADDR) and npj Imaging.
RSC journal affiliations
Associate Editor, RSC Pharmaceutics